Date | Time | Source | Headline | Symbol | Company |
05/06/2016 | 4:53PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
05/06/2016 | 4:11PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
05/02/2016 | 5:43PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
05/02/2016 | 5:43PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
05/02/2016 | 5:42PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
05/02/2016 | 5:42PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
05/02/2016 | 5:40PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
05/02/2016 | 5:39PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
04/29/2016 | 6:37PM | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
04/26/2016 | 7:35AM | Business Wire | ARIAD to Webcast Conference Call on First Quarter 2016 Financial Results | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
04/25/2016 | 4:07PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
04/25/2016 | 4:05PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
04/19/2016 | 7:35AM | Business Wire | ARIAD Announces Results of Preclinical Studies on AP32788 at the Annual Meeting of the American Association for Cancer Research | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
04/15/2016 | 7:35AM | Business Wire | ARIAD Presents Updated Phase 1/2 Clinical Data on Brigatinib in Patients with ALK+ Non-Small Cell Lung Cancer | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
04/11/2016 | 7:35AM | Business Wire | ARIAD Announces Initiation of Randomized, First-Line Phase 3 Trial of Brigatinib in Treatment of ALK-Positive Non-Small Cell ... | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
03/30/2016 | 5:42PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
03/29/2016 | 1:12PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
03/29/2016 | 12:51PM | Business Wire | ARIAD Announces Reduction in Workforce as Part of Ongoing Company-Wide Strategic Review | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
03/23/2016 | 4:43PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
03/22/2016 | 4:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
03/22/2016 | 4:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
03/22/2016 | 4:03PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
03/22/2016 | 4:03PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
03/22/2016 | 4:03PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
03/22/2016 | 4:02PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
03/22/2016 | 4:02PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
03/22/2016 | 4:01PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
03/22/2016 | 7:35AM | Business Wire | ARIAD Reports Inducement Grant to New Chief Financial Officer | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
03/21/2016 | 4:03PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
03/18/2016 | 4:34PM | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |